Top 10 most prescribed drugs 23/24
| Authority | Manx Care |
|---|---|
| Date received | 2024-06-17 |
| Outcome | All information sent |
| Outcome date | 2024-07-16 |
| Case ID | 3921541 |
Summary
A request was made to Manx Care for the top 10 most prescribed drugs and their costs for the 2023/24 financial year. The authority fully disclosed the data, listing the specific medications, item counts, and total actual costs for each.
Key Facts
- The request was received on 2024-06-17 and responded to on 2024-07-16.
- Apixaban 5mg tablets were the most prescribed item by cost at £498,516.20.
- Omeprazole 20mg capsules had the highest volume of items prescribed at 37,367.
- The top 10 list includes anticoagulants, diabetes sensors, and respiratory inhalers.
- All requested information was released without any exemptions applied.
Data Disclosed
- 2023/2024
- 12,775
- £498,516.20
- 3,792
- £268,608.48
- 6,614
- £256,329.88
- 5,795
- £210,008.54
- 37,367
- £136,477.13
- 1,826
- £134,809.43
- 2,224
- £123,665.73
- 1,658
- £118,859.63
- 3,031
- £118,829.05
- 2,170
- £115,005.47
- 2024-06-17
- 2024-07-16
- 3921541
Original Request
Please could you tell me the top ten most prescribed drugs from Manx Care over the period 2023/24 and their cost per unit to Manx Care.
Data Tables (1)
| Financial Year | BNF Presentation | Items | Actual Cost |
|---|---|---|---|
| 2023/2024 | Apixaban 5mg tablets | 12,775 | £498,516.20 |
| 2023/2024 | FreeStyle Libre 2 Sensor | 3,792 | £268,608.48 |
| 2023/2024 | Fostair 100micrograms/dose / 6micrograms/dose inhaler | 6,614 | £256,329.88 |
| 2023/2024 | Apixaban 2.5mg tablets | 5,795 | £210,008.54 |
| 2023/2024 | Omeprazole 20mg gastro-resistant capsules | 37,367 | £136,477.13 |
| 2023/2024 | Rivaroxaban 20mg tablets | 1,826 | £134,809.43 |
| 2023/2024 | Empagliflozin 25mg tablets | 2,224 | £123,665.73 |
| 2023/2024 | Edoxaban 60mg tablets | 1,658 | £118,859.63 |
| 2023/2024 | Fostair 200micrograms/dose / 6micrograms/dose inhaler | 3,031 | £118,829.05 |
| 2023/2024 | Trimbow 87microg/dose / 5microg/dose / 9microg/dose inh | 2,170 | £115,005.47 |
Full Response Text
Manx Care Noble’s Hospital, Strang Braddan, Isle of Man IM4 4R (01624) 650 000
Our ref: 3921541 11 July 2024
Dear ###
We write further to your request, received 17 June 2024, which states:
"Please could you tell me the top ten most prescribed drugs from Manx Care over the period 2023/24 and their cost per unit to Manx Care."
Our response to your request is as follows:
I have detailed below the information that is being released to you:
Financial Year BNF Presentation Items Actual Cost 2023/2024 Apixaban 5mg tablets 12,775 £498,516.20 2023/2024 FreeStyle Libre 2 Sensor 3,792 £268,608.48 2023/2024 Fostair 100micrograms/dose / 6micrograms/dose inhaler 6,614 £256,329.88 2023/2024 Apixaban 2.5mg tablets 5,795 £210,008.54 2023/2024 Omeprazole 20mg gastro-resistant capsules 37,367 £136,477.13 2023/2024 Rivaroxaban 20mg tablets 1,826 £134,809.43 2023/2024 Empagliflozin 25mg tablets 2,224 £123,665.73 2023/2024 Edoxaban 60mg tablets 1,658 £118,859.63 2023/2024 Fostair 200micrograms/dose / 6micrograms/dose inhaler 3,031 £118,829.05 2023/2024 Trimbow 87microg/dose / 5microg/dose / 9microg/dose inh 2,170 £115,005.47
Please quote the reference number 3921541 in any future communications.
Your right to request a review
If you are unhappy with this response to your freedom of information request, you may ask us to carry out an internal review of the response, by completing a complaint form and submitting it electronically or by delivery/post.
An electronic version of our complaint form can be found by going to our website at https://services.gov.im/freedom-of-information/Review . If you would like a paper version of our complaint form to be sent to you by post, please contact me and I will be happy to arrange for this. Your review request should explain why you are dissatisfied with this response, and should be made as soon as practicable. We will respond as soon as the review has been concluded.
If you are not satisfied with the result of the review, you then have the right to appeal
to the Information Commissioner for a decision on;
1. Whether we have responded to your request for information in accordance with
Part 2 of the Freedom of Information Act 2015; or
2. Whether we are justified in refusing to give you the information requested.
In response to an application for review, the Information Commissioner may, at any
time, attempt to resolve a matter by negotiation, conciliation, mediation or another
form of alternative dispute resolution and will have regard to any outcome of this in
making any subsequent decision.
More detailed information on your right to a review can be found on the Information
Commissioner’s website at www.inforights.im.
Should you have any queries concerning this letter, please do not hesitate to contact
me.
Further information about freedom of information requests can be found at
www.gov.im/foi.
I will now close your request as of this date.